|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| C12N 15/13 | (2006.01) | ||
| C12N 15/63 | (2006.01) | ||
| A61K 31/663 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| G01N 33/68 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2586796 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13151551.2 |
| Date of filing the European patent application | 2008-10-10 | |
| (97) | Date of publication of the European application | 2013-05-01 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-07 |
| (46) | Date of publication of the claims translation | 2017-02-27 |
| (30) | Number | Date | Country code |
| 07118414 | 2007-10-12 | EP | |
| 08151911 | 2008-02-25 | EP | |
| 08161342 | 2008-07-29 | EP |
| (72) |
Kneissel, Michaela, CH
Halleux, Christine, CH
Hu, Shou-Ih, US
Diefenbach-Streiber, Beate, DE
Prassler, Josef, DE
|
| (73) |
MEREO BIOPHARMA 3 LIMITED,
4th Floor, One Cavendish Place, London W1G 0QF,
GB
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti naudoti antikūnus prieš sklerostiną |
| Compositions and methods for use for antibodies against sclerostin |
| Payment date | Validity (years) | Amount | |
| 2025-09-02 | 18 | 347.00 EUR |
| 2026-10-10 |